Procter & Gamble Hygiene & Health Care Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 1.42% vs -0.21% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is -0.96% vs 0.57% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -1.97% vs 1.94% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is 88.48% vs -1.55% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of P&G Hygiene With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

1,148.85

1,280.32

-131.47

-10.27%

Other Operating Income

1.32

9.52

-8.20

-86.13%

Total Operating income

1,150.17

1,289.84

-139.67

-10.83%

Raw Material Cost

197.49

463.27

-265.78

-57.37%

Purchase of Finished goods

211.64

262.62

-50.98

-19.41%

(Increase) / Decrease In Stocks

36.07

-36.32

72.39

199.31%

Employee Cost

48.59

105.21

-56.62

-53.82%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

175.97

0.00

175.97

Other Expenses

195.65

184.98

10.67

5.77%

Total Expenditure (Excl Depreciation)

865.41

979.76

-114.35

-11.67%

Operating Profit (PBDIT) excl Other Income

284.76

310.08

-25.32

-8.17%

Other Income

9.90

102.58

-92.68

-90.35%

Operating Profit (PBDIT)

294.66

412.66

-118.00

-28.59%

Interest

3.60

2.72

0.88

32.35%

Exceptional Items

0.00

Gross Profit (PBDT)

291.06

409.94

-118.88

-29.00%

Depreciation

9.28

28.23

-18.95

-67.13%

Profit Before Tax

281.78

381.71

-99.93

-26.18%

Tax

71.92

77.27

-5.35

-6.92%

Provisions and contingencies

0.00

Profit After Tax

209.86

304.44

-94.58

-31.07%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

209.86

304.44

-94.58

-31.07%

Equity Capital

32.46

31.20

1.26

4.04%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

64.65

19.52

45.13

231.20%

Diluted Earnings per share

64.65

19.52

45.13

231.20%

Operating Profit Margin (Excl OI)

24.79%

24.22%

0.00

0.57%

Gross Profit Margin

25.33%

32.02%

0.00

-6.69%

PAT Margin

18.27%

23.78%

0.00

-5.51%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,148.85 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 22.85% vs -5.46% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 1.42% vs -0.21% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 209.86 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 9.27% vs 23.04% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -0.96% vs 0.57% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 284.76 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 6.98% vs 26.96% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -1.97% vs 1.94% in Sep 2024

Quarterly - Interest

Interest 3.60 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 5,042.86% vs -98.79% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 88.48% vs -1.55% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 24.79%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024